Los Alamitos Implements Partial Kratom Ban Amidst Growing Local Scrutiny

Los Alamitos Implements Partial Kratom Ban Amidst Growing Local Scrutiny

Los Alamitos, CA – April 8, 2026 – The city of Los Alamitos has enacted a partial ban on kratom products, joining a growing number of cities in Orange County and across California that are imposing local restrictions on the substance. This decision, following a unanimous vote by city officials, reflects increasing concerns over public access and the safety of certain kratom derivatives.

What Happened

Los Alamitos' new ordinance prohibits the sale of any kratom products to individuals under 21 years of age and specifically bans all products containing 7-hydroxymitragynine (7-OH), the synthetic version of a kratom alkaloid. Additionally, the new rules forbid the marketing of kratom toward children. This action comes after community discussions, including a previously proposed outright ban, and aligns with broader county-level efforts to regulate kratom. While some Orange County cities like Tustin and Newport Beach have instituted blanket bans, others, such as Huntington Beach and Anaheim, have focused on restricting products with higher concentrations of 7-OH.

This local development occurs within a larger statewide context where the California Department of Public Health (CDPH) issued a consumer warning on October 24, 2025, declaring that foods, dietary supplements, and medical drugs containing kratom or 7-OH are dangerous and illegal to sell or manufacture in California. The Department of Alcoholic Beverage Control (ABC) has been actively enforcing this statewide prohibition, with significant product removals from store shelves.

Why It Matters to Kratom Merchants and Consumers

For kratom merchants, the Los Alamitos ban underscores the increasingly fragmented regulatory landscape in California. Despite kratom remaining largely legal at the state level without statewide purchase, possession, or consumption restrictions for adults, local ordinances can create a complex patchwork of varying legality. Merchants operating in California must navigate not only the statewide CDPH warning and ABC enforcement, which effectively makes the sale of kratom as a food, dietary supplement, or medical drug illegal, but also a myriad of local rules. The specific targeting of 7-OH products and age restrictions in Los Alamitos highlights a trend towards stricter controls on particular formulations and consumer demographics.

Consumers, especially those who rely on kratom for personal reasons such as managing chronic pain or opioid withdrawal symptoms, may find their access increasingly limited. Restrictive local bans can inadvertently push consumers towards unregulated online sources or black markets, potentially exposing them to untested and unsafe products.

Compliance Implications

The immediate compliance implication for merchants in Los Alamitos is the strict adherence to the new age restrictions and the complete prohibition of 7-OH products and child-targeted marketing. More broadly, the CDPH's statewide declaration and ABC's enforcement mean that any California merchant selling kratom as a food, dietary supplement, or medical drug, or specifically 7-OH products, faces significant legal risk, including administrative disciplinary action for ABC licensees.

With California lacking comprehensive statewide kratom regulation, the onus is heavily on merchants to stay informed about both state-level warnings and dynamic local ordinances. Efforts to pass a statewide Kratom Consumer Protection Act (KCPA), which would introduce standardized safety standards, age restrictions, and potency limits, are ongoing and could bring more uniform regulation in the future.

What High-Risk Merchants Need to Know About COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, proactive and rigorous compliance measures are paramount. Given the current regulatory climate, robust third-party lab testing and transparent Certificates of Analysis (COAs) are not just best practices, but critical for mitigating risk and demonstrating commitment to consumer safety.

A comprehensive COA should be readily available for every product batch and must include:

• Batch/Lot Identification: A unique number that matches the product's packaging.
• Testing Information: Dates of testing and the analytical methods used.
• Accredited Lab Details: The name and address of the independent, ISO 17025 accredited third-party laboratory that performed the tests.
• Alkaloid Profile: Detailed quantification of key alkaloids, particularly mitragynine and 7-hydroxymitragynine. The American Kratom Association (AKA) recommends that 7-OH should not exceed 2% of the total alkaloids.
• Contaminant Screening: Results for heavy metals (e.g., lead, arsenic, cadmium, mercury), microorganisms (e.g., salmonella, E. coli, mold, yeast), and residual solvents. Look for "Not Detected" or "Below Detectable Limits" for these contaminants.
• Labeling Compliance: Ensure all product labeling includes accurate serving sizes, ingredients, manufacturer/distributor information, and a disclaimer stating the product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

Adhering to Good Manufacturing Practices (GMP) and demonstrating transparency through accessible COAs are vital steps for merchants to differentiate themselves and build trust in a challenging regulatory environment. Continuous monitoring of local, state, and potential federal regulatory changes is essential for long-term compliance and business viability.